Orchid is a company that lets parents genetically test embryos before pregnancy. Parents can choose their future baby for as little as $2,500.
This article features a transcript of an interview with the company’s founder, where they debate the scientific, moral, and ethical implications of designing a ‘healthy’ child and what we lose in separating reproduction from sex.
With Orchid’s technology, parents in the future will not have to roll the dice with their child’s health.
Read the article on The New York Times.
Sources:
• TLDR. (2025, August 8). TLDR Newsletter. https://a.tldrnewsletter.com/web-version?ep=1&lc=f5cb7e17-003d-11ed-9258-0241b9615763&p=1b4e088c-743c-11f0-9e65-d99e8b99940d&pt=campaign&t=1754650745&s=d0b01ae16af233e938426cbe83f939094b3074b1cb098dbfd465732dfcff98a9
• The next parenting trend starts before conception. (2025, August 7). The New York Times. https://www.nytimes.com/2025/08/07/opinion/genetics-children-noor-siddiqui.html
